Insights : service - Osborne Clarke

Competition, antitrust and trade

Competition law is evolving at speed in the UK and the EU. Authorities have been granted new, far-reaching powers to scrutinise investments, subsidies and even entire industries. Enforcement activity has picked up. A wave of antitrust litigation is presenting risks and opportunities for businesses. You need expert lawyers to help you navigate these stormy legal waters.

Article list

Competition, antitrust and trade

English football's new regulator to hand clubs and investors 'state of the game' scorecard

The IFR's report will look to tackle the contentious areas of club finance, ownership structures and parachute payments

New -

10/03/2026

Read time 1m

Competition, antitrust and trade

CMA sets out new guidance on collaborations between UK universities and research institutions

The guidance identifies what higher education providers can and cannot do as they look to work more closely together

New -

09/03/2026

Read time 3m

Competition, antitrust and trade

Sustainability: The French Competition Authority outlines a competition law analytical framework for Citeo's ReUse project in informal guidance

On 4 February 2026, pursuant to the French Competition Authority's (the " FCA") notice on informal guidance in sustainability matters...

26/02/2026

Read time 2m

Regulatory Outlook

Competition | UK Regulatory Outlook February 2026

Consultation launched on major competition regime reforms | New guidance consolidated on market interventions | What are the focus areas...

26/02/2026

Read time 6m

ESG – Environmental, social and governance

ESG Knowledge Update | February 2026

Welcome to our Osborne Clarke ESG Knowledge Update, which offers a round-up of legal, regulatory and market news

13/02/2026

Read time 8m

Competition, antitrust and trade

The UK CMA updates its merger remedies guidance

The regulator may be more open to behavioural remedies, but only where it is satisfied they are effective and proportionate

12/02/2026

Read time 2m

Competition, antitrust and trade

Will there be a more streamlined UK merger control process?

The CMA's procedural overhaul offers merging parties more influence over timing and remedies, but whether it will shorten reviews remains...

10/02/2026

Read time 3m

Competition, antitrust and trade

What does the Getty Images/Shutterstock decision tell business about how the CMA approaches mergers in the UK?

Competition and Markets Authority rejects Getty/Shutterstock remedies, despite focus on growth

06/02/2026

Read time 2m

Competition, antitrust and trade

UK government consults on major reforms to competition processes

The government's growth agenda underlies a set of sweeping and probably controversial proposals

04/02/2026

Read time 3m

Life Sciences and Healthcare

Draft EU medtech revisions adjust importer and distributor roles to support supply chain resilience

Digital obligations, leaner repackaging rules and new shortage reporting tools may evolve supply chain responsibilities

30/01/2026

Read time 7m

Life Sciences and Healthcare

Planned EU medtech changes and codified Helsinki procedure support consistent qualification and classification

EU coordination, expert panel opinions and targeted down classification are proposed to harmonise risk based outcomes

21/01/2026

Read time 7m

Life Sciences and Healthcare

EU drug agency to take broader coordinating role in devices and diagnostics in latest proposal

Expert panel support, shortage coordination and combined study procedures strengthen the EMA's oversight of devices

20/01/2026

Read time 6m

Regulatory Outlook

Competition | UK Regulatory Outlook January 2026

Digital markets | Merger remedies | Civil engineering | Regulatory action plan | Subsidy Control Act

13/01/2026

Read time 3m

Life Sciences and Healthcare

Proposed EU medtech laws seek more predictable and efficient notified body oversight

Structured dialogue, streamlined sampling, extended audits and SME‑friendly fees to reshape device conformity assessment

13/01/2026

Read time 8m

Life Sciences and Healthcare

EU revised device rules rebalance compliance towards simplification and proportionality

Commission proposal would streamline MDR and IVDR duties with flexible evidence, timeless certificates and tailored risk rules

09/01/2026

Read time 9m

View all insights

Competition, antitrust and trade

English football's new regulator to hand clubs and investors 'state of the game' scorecard

The IFR's report will look to tackle the contentious areas of club finance, ownership structures and parachute payments

New -

10/03/2026

Read time 1m

Competition, antitrust and trade

CMA sets out new guidance on collaborations between UK universities and research institutions

The guidance identifies what higher education providers can and cannot do as they look to work more closely together

New -

09/03/2026

Read time 3m

Competition, antitrust and trade

Sustainability: The French Competition Authority outlines a competition law analytical framework for Citeo's ReUse project in informal guidance

On 4 February 2026, pursuant to the French Competition Authority's (the " FCA") notice on informal guidance in sustainability matters...

26/02/2026

Read time 2m

Regulatory Outlook

Competition | UK Regulatory Outlook February 2026

Consultation launched on major competition regime reforms | New guidance consolidated on market interventions | What are the focus areas...

26/02/2026

Read time 6m

ESG – Environmental, social and governance

ESG Knowledge Update | February 2026

Welcome to our Osborne Clarke ESG Knowledge Update, which offers a round-up of legal, regulatory and market news

13/02/2026

Read time 8m

Competition, antitrust and trade

The UK CMA updates its merger remedies guidance

The regulator may be more open to behavioural remedies, but only where it is satisfied they are effective and proportionate

12/02/2026

Read time 2m

Competition, antitrust and trade

Will there be a more streamlined UK merger control process?

The CMA's procedural overhaul offers merging parties more influence over timing and remedies, but whether it will shorten reviews remains...

10/02/2026

Read time 3m

Competition, antitrust and trade

What does the Getty Images/Shutterstock decision tell business about how the CMA approaches mergers in the UK?

Competition and Markets Authority rejects Getty/Shutterstock remedies, despite focus on growth

06/02/2026

Read time 2m

Competition, antitrust and trade

UK government consults on major reforms to competition processes

The government's growth agenda underlies a set of sweeping and probably controversial proposals

04/02/2026

Read time 3m

Life Sciences and Healthcare

Draft EU medtech revisions adjust importer and distributor roles to support supply chain resilience

Digital obligations, leaner repackaging rules and new shortage reporting tools may evolve supply chain responsibilities

30/01/2026

Read time 7m

Life Sciences and Healthcare

Planned EU medtech changes and codified Helsinki procedure support consistent qualification and classification

EU coordination, expert panel opinions and targeted down classification are proposed to harmonise risk based outcomes

21/01/2026

Read time 7m

Life Sciences and Healthcare

EU drug agency to take broader coordinating role in devices and diagnostics in latest proposal

Expert panel support, shortage coordination and combined study procedures strengthen the EMA's oversight of devices

20/01/2026

Read time 6m

Regulatory Outlook

Competition | UK Regulatory Outlook January 2026

Digital markets | Merger remedies | Civil engineering | Regulatory action plan | Subsidy Control Act

13/01/2026

Read time 3m

Life Sciences and Healthcare

Proposed EU medtech laws seek more predictable and efficient notified body oversight

Structured dialogue, streamlined sampling, extended audits and SME‑friendly fees to reshape device conformity assessment

13/01/2026

Read time 8m

Life Sciences and Healthcare

EU revised device rules rebalance compliance towards simplification and proportionality

Commission proposal would streamline MDR and IVDR duties with flexible evidence, timeless certificates and tailored risk rules

09/01/2026

Read time 9m

View all insights

Belgium

China

France

Germany

India

Italy

Poland

Singapore

Spain

Sweden

The Netherlands

UK

USA

Insights

Competition, antitrust and trade

Article list

Sign up for our newsletter

Legal Notice